ArticleMagnetic resonance in medicine2026
Simultaneous Cerebral Blood Flow and Cerebrovascular Reactivity Obtained From Novel Multi-Band Multi-Echo Pseudo-Continuous Arterial Spin Labeling (M2-PCASL) Sequence: A Test-Retest Reliability Study.
Article in Magnetic resonance in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
purposeWe aim to assess the reliability of cerebral blood flow (CBF) and cerebrovascular reactivity (CVR) obtained simultaneously from a novel multi-band pseudo-continuous arterial spin labeling (M2-PCASL) sequence and hypercapnic gas challenge, to examine factors influencing CBF variability, and to evaluate the impact of carbon dioxide (CO
methodsNine participants underwent test-retest M2-PCASL scans at 3T with hypercapnia to quantify CBF and CVR. Reliability was assessed using the intraclass correlation coefficient (ICC) at whole brain, region of interest (ROI), and voxel levels. Linear mixed-effect models were used to investigate factors contributing to CBF variability. Independent samples t-tests were used to compare BOLD CVR and temporal contrast to noise ratio (tCNR) from different CO
resultsWith smoothing, the M2-PCASL sequence estimated baseline CBF and BOLD CVR with good to excellent reliability (ICC > 0.81) in the whole brain, gray matter (GM), and white matter (WM). Average ICCs across the Automated Anatomical Labeling atlas ROIs were between 0.50 ± 0.30 and 0.69 ± 0.19. CBF CVR achieved fair to moderate reliability in GM (ICCs between 0.42 and 0.55). Head motion was significantly associated with CBF temporal SNR (p ≤ 0.002). 5% and 8% CO
conclusionThe M2-PCASL sequence with hypercapnia reliably estimates baseline CBF and BOLD CVR at improved spatial and temporal resolutions relative to existing methods, enabling us to noninvasively and comprehensively assess cerebrovascular health.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.